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Abstract Background
Pulmonary embolism is considered to originate from embolization of a deep-vein thrombosis, resulting in two manifestations of one disease: venous thrombosis.
However, in up to 50% of patients with pulmonary embolism no deep-vein thrombosis is found with ultrasonography. An explanation for this low proportion is currently lacking. Other imaging modalities may increase deep-vein thrombosis yield in the calf or in the abdominal region. Alternatively, not all pulmonary emboli may originate from deep-vein thrombosis in the extremities. We searched for the origin of pulmonary embolism, by performing total-body Magnetic Resonance
Imaging-scans to visualize thrombi.
Design and Methods
99 patients with a Computed Tomography confirmed first pulmonary embolism underwent a Magnetic Resonance Direct Thrombus Imaging-scan, a validated technique using endogenous contrast. Additionally, acquired and genetic risk factors were assessed.
Results
No thrombus was found in 55 patients, leaving 44 patients with thrombus. The commonest origin was the lower leg; 12 patients had isolated calf vein thrombosis, 5 had isolated superficial vein thrombosis.
Conclusions
In less than half of patients with pulmonary embolism a peripheral thrombus was found with Magnetic Resonance Imaging. We proposed several hypotheses to explain the absence of thrombi, such as cardiac thrombus origin or embolization of the complete deep-vein thrombosis. The possibility that pulmonary embolism arises de novo in the lungs, due to local inflammation driven coagulation, needs to be considered.
Introduction
Since autopsy studies by Virchow in the mid 1800s, pulmonary embolism (PE) is thought to originate from embolization of a deep-vein thrombosis (DVT), resulting in two clinical manifestations of one disease: venous thrombosis (VT). However, in up to 50% of patients with PE no DVT is found with ultrasonography or contrast venography studies. [1] [2] [3] [4] [5] [6] A suitable explanation for this low proportion is currently lacking.
Compression ultrasonography (CUS) is presently the leading diagnostic modality for the diagnosis of DVT, with a sensitivity of 96% and specificity of 98%
for symptomatic proximal DVT. 7 A disadvantage of CUS is its reduced accuracy when it comes to below knee thrombi or pelvic thrombi. Thrombi in the calf veins extend to proximal veins in 20-30% of cases, and may embolize from the calves or after extension, contributing to PE occurrence. 8 Calf veins and pelvic veins may be an overlooked source of PE that could explain the 20-50% of thrombi missed by CUS imaging. Therefore, other imaging modalities may lead to a larger yield of DVTs, both in the abdominal and pelvic region as in the calf veins.
Combined CT pulmonary angiography (CTPA) and CT venography has been performed to search for abdominal thrombi. By extending the scan from the lungs to the pelvis and legs, Nchimi et al. found 10% of DVTs above the inguinal ligament.
9
A validated, new and highly sensitive technique in diagnosing DVT is magnetic resonance direct thrombus imaging (MRDTI). 10, 11 This is a non-invasive technique without the need of gadolinium contrast. Unlike most imaging techniques, which show the thrombus as a filling defect, MRDTI shows the thrombus itself and suppresses background signal. This method is based on the transformation of haemoglobin into methemoglobin when a thrombus is formed.
Using a T1 sequence, methemoglobin in the thrombus gives a high signal that disappears after about 6 months. A sensitivity of 98% and a specificity of 96%
were found for MRDTI compared with ultrasound or venography in 101 patients with symptomatic DVT. 10 Since physical accessibility of veins plays no role in MRI, this method allows visualization of thrombi at all anatomical loci. The presence of a pacemaker was an exclusion criterion for the study. In addition, claustrophobia and high body weight were contraindications to undergo MRI scanning. No strict cut-off for body weight was applied, as the distribution of body weight was more important than weight itself to fit into the scanner.
A questionnaire on risk factors for VT was filled in by all patients. The questionnaire contained questions on family history of VT, recent travel, surgery, cancer, and use of the contraceptive pill. As atrial fibrillation may give rise to thrombus formation in the right heart, and could thereby be a possible source of PE, electrocardiograms (ECGs) were reviewed as well as the medical charts.
Patients were categorized as "atrial fibrillation positive" when they had a documented history of atrial fibrillation, or when the ECG made at the time of PE diagnosis showed atrial fibrillation, and negative when otherwise. Blood was drawn for analysis of the factor V Leiden and prothrombin G20210A mutation.
These were determined by polymerase chain reactions using the TaqMan assay.
A detailed description of these methods has been published previously. 25 In case blood draws were not possible, DNA was collected via a buccal swab.
The total-body scan was performed on a Philips 1. 11, 26 The MRI protocol has been described more extensively in a review on MR imaging of venous thrombosis. 27 Pulmonary structures (including the pulmonary arteries) could not be imaged with the MRDTI scan we used, due to the free-breathing scanning protocol. Therefore, we did not attempt to confirm the PEs detected by CTPA by MRI.
We aimed to enroll 100 patients with a first PE in this observational study.
We assessed the anatomic location of DVTs, the number of affected veins per patient, and whether the affected veins were proximal or distal. The predefined venous segments of the anatomical localization of thrombi are shown in Figure 2 (independent of the side of DVT). We found 16 (36%) patients with a thrombosis on MRI to have an occlusion in both the upper and lower leg.
The most common origin was the lower leg; here 12 patients (27%) had isolated deep calf vein thrombosis, and 5 (11%) presented with isolated superficial vein thrombosis confined to the calf. Abdominal thrombi were rare (3 patients, 7%).
We assessed common acquired and genetic risk factors in all participants (Table 3 ). Overall, 21% of patients were aged over 65 years. One in four patients had an active malignancy at the time of PE diagnosis. A similar percentage was found for recent surgery. These risk factors were equally present in PE patients with and without a DVT on MRI. Minor leg injuries were present more often in patients with DVT than in those without DVT, in 11% and 5% respectively. One or more immobilization risk factors (i.e., bedrest of more than four days in the past eight weeks, air travel of more than eight hours, travel by car or train longer than four hours) were present in 27% of patients with DVT, and in 41% of patients without DVT. As for the two genetic risk factors that were measured in this study, we found a higher prevalence of factor V Leiden in patients with DVT on MRI (14%) than in those without DVT (7%). For the prothrombin (G20210A) mutation, prevalences did not differ much, i.e., 4% in PEs without DVT and 2% in PEs with DVT.
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Discussion
We performed a total-body MRI scan in 99 patients with PE, and could not detect a peripheral thrombus in more than half of the patients. We had expected to detect thrombi in the majority of cases, and a substantial number in the abdominal or pelvic region where CUS cannot readily detect thrombi. In the following section we present different potential explanations for these surprising findings, some of which we can reject. found that of 13 patients, 10 had a DVT. The MRI showed a DVT in 9 out of these 10 patients (i.e., a sensitivity of 90%). The DVT that was missed was a (deep) calf vein thrombosis of the left leg. Therefore, even when we assume that not all DVTs were detected by MRDTI scanning, this explanation may account for some, but is unlikely to account for 56% of missing thrombi.
Explanation 2: PEs without a DVT on MRI are due to "therapeutic embolization"
This explanation comprises that in patients with PE without DVT on MRI, a DVT had been present but was completely dislodged to the pulmonary arteries at the time of scanning. Yet, this theory seems unlikely as an explanation for all of the missing DVTs, as is supported by data from postmortem studies. These studies showed that only part of the clot (usually the free-floating tail) breaks off and embolizes. [29] [30] [31] Furthermore, one would expect that more time between diagnosis of PE and MRI scanning would be related to a lower chance of finding a thrombus. We performed a logistic regression analysis to address this question, using the presence or absence of DVT as an outcome and the number of days between PE diagnosis and MRI scan as a continuous covariable. Our data showed no association between identification of a DVT and the number of days between diagnosis and MRI, with an OR of 0.99 (95% CI 0.81-1.21).
Explanation 3: PE has a cardiac origin
Case reports describing PE due to right atrial thrombi in atrial fibrillation have led us to consider this as an alternative origin of PE. 32, 33 In a recent case-control study based on ICD discharge codes in the Danish National Patient Registry, heart disease was shown to be a risk factor for PE without concomitant DVT, with an over 40-fold increased risk for the first three months after myocardial infarction or heart failure. 34 For DVT with or without PE, this risk was 10-to 20-fold increased. The risk was more pronounced for right-sided heart disease, suggesting a direct relation with the thrombus in the pulmonary arteries. Two previous studies also showed that patients with atrial fibrillation, mitral valve stenosis or dilated cardiomyopathy are at increased risk to develop isolated PE.
The authors concluded that heart diseases could be a source of PE, due to the development of right-sided cardiac thrombi. 35, 36 In our study, in the group of PE patients without DVT on MRI, there were no patients with documented heart failure. Two out of 55 patients had atrial fibrillation (4%). The absence of heart failure and the low proportion of atrial fibrillation make it unlikely that cardiac thrombi would explain the absence of DVTs in over half of the PE patients.
Explanation 4: PE originates from local thrombus formation in the lungs
From an alternative etiological point of view, PE may be a local phenomenon, starting in the pulmonary arteries. Previously, the hypothesis has been proposed of central PE being caused by DVT and peripheral, smaller PE being caused by local inflammatory reactions in the pulmonary arteries. 31 The idea of PE due to local inflammatory processes was described in two studies performed in trauma patients. 31, 37 Autonomic dysfunction is one of the consequences of trauma, which may lead to adrenergia and inflammation that together promote coagulation.
Hypoxia may also activate the endothelium. 31, 37 Yun et al. conclude that embolic disorders such as PE may represent asynchronous systemic phenomena rather than a clot migration process, when adrenergia and inflammation are present. 38 In addition, COPD and asthma may cause local clots, as persistent low-level systemic inflammation is present in these patients. 22, 24 Data from a nested casecontrol study showed a 3.6-fold increased risk of PE for patients with mild COPD, and a 7.5-fold increased risk of PE for severe COPD. No increased risk was found for DVT. 22 We recently found that pneumonia increased the risk of PE in the MEGA study, with an OR of 8.1 (95% CI 6.2-10.6). For DVT alone, the OR was 3.0 (95% CI 2.2-4.0). 23 Inflammation affects coagulation via different mechanisms: via tissue factor mediated thrombin generation, and via the impairment of anticoagulant pathways, the protein C system in particular. 39 In asthma patients impaired fibrinolysis has been described. Protease-activated receptors have been pointed out as the molecular link between coagulation and allergic inflammation in asthma. 24 In addition, coagulation can be further enhanced by the complement system that is activated during inflammation. One might speculate on local inflammation of the vessel wall leading to thrombus formation.
Another argument that supports the possibility of local PE is that of recurrent events. If DVT and PE are manifestations of the same disease, the anatomical location of recurrence would be expected to be independent of the location of the first event. However, PE patients are more likely to develop another PE when a recurrence occurs, while patients with DVT recur as a DVT more often than expected. 40 In addition, patients with isolated PE are less likely to experience a recurrent event than DVT patients, confirming that isolated PE may be a different entity. are not comparable to our study methods, as we did not select patients with a negative CUS, but only with a CTPA proven PE. 47 Of the risk factors we analyzed, the most noticeable finding was that the factor V Leiden mutation was present more often (14%) in PE patients with a concomitant DVT, than in patients with PE alone (7%). This confirms previous findings, which showed that patients with both PE and DVT resemble the DVT patients more than the isolated PE patients concerning factor V Leiden prevalence. 13 As for minor leg injuries, it seems plausible that patients with an injury of the leg are likely to develop a DVT locally, part of which could embolize later. 19 Isolated PE patients indeed had a lower prevalence (5%) of minor leg injuries than patients with a concomitant DVT (11%). A limitation to this study is numbers were small for assessment of differences in risk factors between patients with and without a DVT. Therefore the results that we found have to be interpreted carefully and need to be replicated in larger studies.
In summary, in this etiological study we aimed to locate the origin of PE and thereby increase the yield of DVTs that were otherwise missed on CUS examinations. We found DVT in less than half of all PE patients using a totalbody MRI technique, and proposed several hypotheses to explain the absence of DVTs in the majority of patients. Limited sensitivity of MRDTI, complete embolization of the DVT, or a cardiac clot origin could not sufficiently explain the absence of thrombi. We postulate therefore that in some cases PE may arise de novo in the lungs, which could be a new explanation for the origin of PE without concomitant DVT. 
